Back to RecallTracker
Health Canada Health products

JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling

Issued June 22, 2023
Issue
An incorrect label (Venlafaxine XR 37.5 mg) is attached to some units of the affected lot which contains: Venlafaxine XR 150 mg.
Hazard description
Labelling
What to do
Check the capsules in your pharmacy bottle of JAMP Venlafaxine XR 37.5 mg capsules to make sure it contains 37.5 mg capsules (grey / pink in colour) and not 150 mg capsules (caramel in colour). If you are unsure, contact your pharmacist to check if your bottle contains the correct capsules. If you see incorrect capsules, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal . Contact your health care professional if you have taken the wrong dose of your medication. Seek medical attention immediately if you experience any serious side effects from Venlafaxine XR, which may include allergic reactions, gastrointestinal bleeding, seizures, heart rhythm problems, blurred vision, eye pain, or severe headache. Contact JAMP Pharma Corporation by email at alewicki@jamppharma.com if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.
Product
Product name
JAMP Venlafaxine XR 37.5 mg capsules
Reference
ID
RA-73865